Long non-coding RNA implicated in triple negative breast cancer
A slice of RNA that doesn’t code for a protein manages to stifle tumor-suppressing genes and wreck the cellular mechanism that flags cancer cells for destruction by the immune system.
Writing this month in Nature Immunology, a team led by scientists at MD Anderson shows that the long, non-coding RNA (lncRNA) called LINK-A is a potential therapeutic target for triple negative breast cancer.
Working in a uniquely developed...
MD Anderson advances novel therapeutic antibody into AML clinical trials
Leukemia researchers at The University of Texas MD Anderson Cancer Center, working collaboratively with the Therapeutics Discovery division...
Triple combination shows promise against advanced melanoma
Combining two types of drugs that, separately, have extended the lives of people with metastatic melanoma has yielded higher response rates...
V. Craig Jordan honored by Queen Elizabeth II for impact on women’s health
V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been recognized for his “services to women’s health” with his appointment by Queen Elizabeth II as a Companion (CMG) of the Most Distinguished Order of St. Michael and St. George, announced June 7 as part of the Queen’s Birthday Honours list tradition in the United Kingdom.
It’s the latest honor for Jordan’s discovery and development of selective estrogen receptor...
Hortobagyi honored by ASCO for his work against breast cancer
Improvements in breast cancer treatment over the past five decades have reduced the mortality rate of women with the disease by 40 percent...